Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of Oncology

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDH095PMID 14998849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The nitric oxide donor, V‐PYRRO/NO, protects against acetaminophen‐induced hepatotoxicity in mice

  2003cited by this paper
• Oxaliplatin-related side effects: characteristics and management.

  2002cited by this paper
• The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.

  2002cited by this paper
• Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

  2002cited by this paper
• Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.

  2002cited by this paper
• Oxaliplatin: results in colorectal carcinoma.

  2002cited by this paper
• Cellular Retinol-Binding Protein-1 Expression and Modulation during In Vivo and In Vitro Myofibroblastic Differentiation of Rat Hepatic Stellate Cells and Portal Fibroblasts

  2002influential reference
• Surgical management of hepatic metastases from colorectal malignancies.

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

  2001cited by this paper
• Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells.

  2000cited by this paper
• Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

  2000cited by this paper
• Oxaliplatin clinical activity: a review.

  2000cited by this paper
• Support of sinusoidal endothelial cell glutathione prevents hepatic veno‐occlusive disease in the rat

  2000cited by this paper
• Role of Oxidative Stress and Glutathione in Busulfan Toxicity in Cultured Murine Hepatocytes

  2000cited by this paper
• Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Hepatic arterial chemotherapy in metastatic colorectal patients.

  1999cited by this paper
• Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.

  1999cited by this paper
• Characterization of a reproducible rat model of hepatic veno‐occlusive disease

  1999cited by this paper
• Hepatic stellate cells (Ito cells) in veno‐occlusive disease of the liver after allogeneic bone marrow transplantation

  1999cited by this paper
• Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy.

  1998cited by this paper
• Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

  1998cited by this paper
• Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver

  1997cited by this paper
• Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease

  1996cited by this paper
• The syndrome of hepatic veno-occlusive disease after marrow transplantation.

  1995cited by this paper
• The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits.

  1995cited by this paper
• Factors influencing the natural history of colorectal liver metastases.

  1994cited by this paper
• Nodular Regenerative Hyperplasia in Partial Hepatectomy Specimens

  1993cited by this paper
• Hepatocyte membrane injury and bleb formation following low dose comfrey toxicity in rats.

  1993cited by this paper
• micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules

  1990cited by this paper

• Investigating Genetic Risk to Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Colorectal Cancer Through Routinely Available NGS Data.

  2026cites this paper
• Thrombocytosis in cancer patients: when more is not better—in fact, the opposite

  2026cites this paper
• Surgery for colorectal liver metastases: Predictive factors of biliary fistula

  2026cites this paper
• How to Integrate Surgery into the Multidisciplinary Treatment of Liver-Only Metastatic Colorectal Cancer

  2026cites this paper
• Surgical Management of Colorectal Cancer Liver Metastases.

  2025cites this paper
• Inhibition of MALT1 Protease Attenuates Hepatic Sinusoidal Obstruction Syndrome by Modulating NRF2/HO1 and NF‐κB Pathway

  2025cites this paper
• Efficacy and safety of oxaliplatin-based chemotherapy as first-line treatment in elderly patients with metastatic colorectal cancer: a meta-analysis

  2025cites this paper
• Managing dual primary liver metastases from breast and colorectal cancers

  2025cites this paper
• Multimodal therapy and precision-imaging extends the limits of treatment for a patient with initially unresectable synchronous colorectal liver metastases

  2025cites this paper
• Hypointense Findings on Hepatobiliary Phase MR Images.

  2025cites this paper
• Histopathological analysis of tumor microenvironmental changes after near-infrared photoimmunotherapy

  2025cites this paper
• Potential risk of ramucirumab-induced liver failure associated with prior use of oxaliplatin in patients with metastatic gastric cancer: a case report

  2025cites this paper
• An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.

  2025cites this paper
• EASL Clinical Practice Guidelines on vascular diseases of the liver.

  2025cites this paper
• Management of surgically resectable colorectal liver metastases in older patients.

  2025cites this paper
• Platelet aggregation elicits FasL expression and hepatocyte apoptosis in sinusoidal obstruction syndrome

  2025cites this paper
• Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases

  2025influential citation
• Hepatotoxicity of Chemotherapy and Immune Checkpoint Inhibitors.

  2025cites this paper
• Early unresectable relapse after hepatic resection for colorectal liver metastases: a focus on time to surgical failure

  2025cites this paper
• Assessment of non-tumor liver parenchyma damage in advanced gastric cancer treatment with transarterial infusion chemotherapy: a study using imaging and hepatic injury indicators

  2025cites this paper
• Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer

  2025cites this paper
• S-Adenosylmethionine Inhibits Plasminogen-Activating Inhibitor-1 and Protects Male Mice from FOLFOX-Induced Liver Injury

  2025cites this paper
• Role of gadoxetic acid-enhanced MRI in the differential diagnosis of chemotherapy-induced focal nodular hyperplasia-like lesions and liver metastases in patients with colorectal cancer

  2024cites this paper
• Clinical benefits of partial splenic embolization for cancer patients

  2024cites this paper
• Hepatic Sinusoidal Disorders.

  2024cites this paper
• Intrahepatalna portalna hipertenzija uzrokovana oksaliplatinom u liječenju karcinoma želuca – prikaz bolesnika i pregled literature

  2024cites this paper
• Inhibitory Effects of Flavonoids on Organic Cation Transporter 1: Implications for Food/herb-drug Interactions and Hepatoprotective Effects.

  2024cites this paper
• Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study

  2024cites this paper
• Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes

  2024influential citation
• Posthepatectomy Liver Failure in Patients with Splenomegaly Induced by Induction Chemotherapy for Colorectal Liver Metastases

  2024cites this paper
• Acupuncture ameliorates liver injury induced by platinum treatment through the Notch signaling pathway

  2024cites this paper
• Perioperative outcomes of sinusoidal obstruction syndrome in patients undergoing liver resection for colorectal metastases after neoadjuvant chemotherapy: a retrospective cohort research

  2024cites this paper
• Nodular Hyperplasia Mimicking Colon Cancer Liver Metastasis

  2024cites this paper
• Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma

  2024cites this paper
• The “appearing” and “disappearing” ascites in the treatment of colorectal cancer: a case report

  2024cites this paper
• Preoperative chemotherapy in upfront resectable colorectal liver metastases: New elements for an old dilemma?

  2024cites this paper
• Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies

  2024cites this paper
• Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome

  2024cites this paper
• The Relationship between Liver Volume, Clinicopathological Characteristics and Survival in Patients Undergoing Resection with Curative Intent for Non-Metastatic Colonic Cancer

  2024cites this paper
• Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases

  2024cites this paper
• Clinical features and risk factors of hepatic sinusoidal obstruction syndrome in children after hematopoietic stem cell transplantation: A single-center experience.

  2024cites this paper
• Tumour response following preoperative chemotherapy is affected by body mass index in patients with colorectal liver metastases

  2024cites this paper
• Sarcopenia does not affect liver regeneration and postoperative course after a major hepatectomy. A prospective study on 125 patients using CT volumetry and HIDA scintigraphy.

  2024cites this paper
• Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.

  2024cites this paper
• Assessment and treatment considerations for patients with colorectal liver metastases: AHPBA consensus guideline and update for surgeons.

  2024cites this paper
• [A Case Report of Successful Treatment with Dose-controlled mFOFOX6+Bevacizumab for Metastatic Colorectal Cancer in Patient Receiving Hemodialysis].

  2024cites this paper
• Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives

  2024cites this paper
• Huaier relieves oxaliplatin-induced hepatotoxicity through activation of the PI3K/AKT/Nrf2 signaling pathway in C57BL/6 mice

  2024cites this paper
• Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer

  2024cites this paper
• A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study

  2023cites this paper
• Morphology of immune-mediated hepatitis: A comparison between immune checkpoint inhibitor therapy and combined immune checkpoint inhibitor/anti-angiogenic therapy.

  2023cites this paper
• Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

  2023cites this paper
• Advanced age; not a contraindiction for resections of colorectal liver metastasis recurrence

  2023cites this paper
• Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case–control study

  2023cites this paper
• The Role of the Multiparametric MRI LiverMultiScanTM in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis

  2023influential citation
• オキサリプラチンによるSOSは造血幹細胞移植によるSOSと一線を画する？

  2023cites this paper
• Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out?

  2023cites this paper
• Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury.

  2023cites this paper
• Schistosoma japonicum Associated Colorectal Cancer and Its Management

  2023cites this paper
• Splenic hypertrophy predicts liver-specific complications in patients undergoing major liver resection for colorectal liver metastases, after preoperative chemotherapy

  2023cites this paper
• A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX

  2023cites this paper
• Yes, you should do a magnetic resonance imaging (MRI) for patients scheduled for local therapy of colorectal cancer liver metastases: insights into the CAMINO study

  2023cites this paper
• Idiopathic hypereosinophilic syndrome with hepatic sinusoidal obstruction syndrome: A case report and literature review

  2023cites this paper
• Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy

  2023cites this paper
• Naringin attenuates oxaliplatin‐induced nephrotoxicity and hepatotoxicity: A molecular, biochemical, and histopathological approach in a rat model

  2023cites this paper
• Impact of preoperative chemotherapy on perioperative morbidity in combined resection of colon cancer and liver metastases

  2023cites this paper
• Pirarubicin loaded biodegradable nanoparticles downregulate IL-6, COX-II and TNF-α along with oxidative stress markers in comparison to conventional pirarubicin in healthy albino rats

  2023cites this paper
• Unique Morphologic Findings in the Liver After Stereotactic Radiation for Cholangiocarcinoma

  2023cites this paper
• Autotaxin is a novel surrogate marker for oxaliplatin‐related sinusoidal obstruction syndrome in patients with colorectal liver metastasis

  2023cites this paper
• Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer

  2023cites this paper
• The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China

  2023cites this paper
• The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients

  2023cites this paper
• Postoperative Chemotherapy After Surgical Resection of Metachronous Metastases of Colorectal Cancer: A Systematic Review

  2023cites this paper
• Isolinderalactone Resistance to the Liver Injury Induced by Oxaliplatin in Rats through Inhibiting IL-6/STAT3 Signal Pathway.

  2023cites this paper
• Effect of Preoperative Chemotherapy on the Isolation Outcome of Primary Human Hepatocytes

  2023cites this paper
• Transatlantic registries for minimally invasive liver surgery: towards harmonization

  2023cites this paper
• Extracellular Volume Fraction Calculated Using Contrast-Enhanced Computed Tomography as a Biomarker of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: A Preliminary Histopathological Analysis

  2023cites this paper
• Post-chemotherapy liver atrophy does not impact the outcome after hepatectomy performed under a parenchymal-sparing approach

  2023cites this paper
• A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases

  2023cites this paper
• Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer

  2023cites this paper
• Predictive Model of Oxaliplatin-induced Liver Injury Based on Artificial Neural Network and Logistic Regression

  2023cites this paper
• Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma

  2023cites this paper
• Case report: Oxaliplatin-induced idiopathic non-cirrhotic portal hypertension: a case report and literature review

  2023cites this paper
• Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality

  2023cites this paper
• Chinese expert consensus on managing thrombocytopenia in patients with cancer and liver injury

  2023cites this paper
• Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma

  2023cites this paper
• Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases

  2023cites this paper
• Chemotherapy-Induced Liver Injury in Patients with Colorectal Liver Metastases: Findings from MR Imaging

  2022influential citation
• Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model.

  2022cites this paper
• Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference

  2022cites this paper
• Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites

  2022influential citation
• A radiological footprint equivalent to liquefactive necrosis observed in the course of disappearing liver metastases in rectal cancer: A case report and review of the literature

  2022cites this paper
• Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies.

  2022cites this paper
• Role of 4-methylimidazole in liver toxicity: A histomorphometric study in albino rats

  2022cites this paper
• Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Liver Failure After Resection of Colorectal Liver Metastases

  2022cites this paper
• Indocyanine green clearance test as a predictor of chemotherapy liver toxicity and post-operative complications in patients with colorectal liver metastases.

  2022cites this paper
• Hyaluronic Acid May Be a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy.

  2022cites this paper
• Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial)

  2022cites this paper
• Predictive factors of collateral vessel development induced by oxaliplatin-based chemotherapy

  2022cites this paper
• MgIG Attenuates Oxaliplatin-induced Hepatotoxicity through Suppression of Connexin 43 in Hepatic Stellate Cells

  2022cites this paper